Zur-Rose sets terms on rights issue, will price to market
GlobalCapital, is part of the Delinian Group, DELINIAN (GLOBALCAPITAL) LIMITED, 4 Bouverie Street, London, EC4Y 8AX, Registered in England & Wales, Company number 15236213
Copyright © DELINIAN (GLOBALCAPITAL) LIMITED and its affiliated companies 2024

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement
EquityFollow-ons and Rights issues

Zur-Rose sets terms on rights issue, will price to market

Pharma,

Zur-Rose, the Swiss retail pharmacy, has set the terms on its Sfr200m new share issuance, to fund the acquisition of Medpex’s e-commerce activities.

Unlock this article.

The content you are trying to view is exclusive to our subscribers.

To unlock this article:

Request a Free Trial or Login
Gift this article